基本信息
浏览量:0
职业迁徙
个人简介
He is an accomplished clinician scientist with more than two decades of experience in antifungal pharmacotherapy. Dr. Rogers maintains fruitful collaborative efforts within and outside the institution as he directs discovery efforts to elucidate the molecular and genetic basis of fungal pathogen resistance. He has been continually funded by the NIH since 2000 and is the recipient of over $12 million in NIH funding as a principal investigator. In 2021, Dr. Rogers was recognized with the American College of Clinical Pharmacy’s Russell R. Miller Award and Therapeutics Frontiers Lecture Award. Dr. Rogers is a distinguished alumnus of University of Mississippi Medical Center School of Graduate Studies in Health Sciences and recognized for his teaching excellence at UTHSC.
研究兴趣
论文共 151 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jinhong Xie, Jeffrey M Rybak,Adela Martin-Vicente, Xabier Guruceaga, Harrison I Thorn,Ashley V Nywening,Wenbo Ge,Josie E Parker,Steven L Kelly,P David Rogers,Jarrod R Fortwendel
Nature communicationsno. 1 (2024): 4261-4261
Jeffrey M Rybak, Jinhong Xie,Adela Martin-Vicente, Xabier Guruceaga, Harrison I Thorn,Ashley V Nywening,Wenbo Ge, Ana C O Souza,Amol C Shetty,Carrie McCracken,Vincent M Bruno,Josie E Parker,
Sean Bergin, Laura A Doorley,Jeffrey M Rybak,Kenneth H Wolfe,Geraldine Butler,Christina A Cuomo,P David Rogers
Antimicrobial agents and chemotherapypp.e0161923-e0161923, (2024)
Jinhong Xie,Jeffrey M. Rybak,Adela Martín‐Vicente,Xabier Guruceaga, Harrison Thorn,Ashley V. Nywening,Wenbo Ge,Josie E. Parker,Steven L. Kelly,David A. Rogers,Jarrod R. Fortwendel
bioRxiv (Cold Spring Harbor Laboratory) (2023)
引用0浏览0引用
0
0
bioRxiv : the preprint server for biology (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn